• Personal Stories

How serendipity sent this oncologist in search of a cure for cancer

Dr Hugo De La Peña, the face of our latest TV advert, explains how a second chance at life led to a career dedicated to curing cancer.   Dr Hugo De La Peña, the face of our latest TV advert, explains how a second chance at life led to a career dedicated to curing cancer.  

12 August 2022

• Health & Medicine

A Cancer Revolution: What the experts think of the new Science Museum exhibition

We spoke to Dr Vivian Li and Rupal Mistry about their thoughts on the Cancer Revolution exhibition at the Science Museum. We spoke to Dr Vivian Li and Rupal Mistry about their thoughts on the Cancer Revolution exhibition at the Science Museum.

25 July 2022

• For Researchers

Joining the dots: How our new research data strategy will unlock the power of big data

To capitalise on the reams of data produced by cancer researchers we must have a joined up approach - here's how our new strategy will help To capitalise on the reams of data produced by cancer researchers we must have a joined up approach - here's how our new strategy will help

7 July 2022

• Health & Medicine

Closing the gap: How new screening interventions could reduce inequalities in bowel cancer outcomes

If we can find interventions that help to increase participation in screening programmes amongst lower income groups, we may be able to reduce the health inequalities that exist in bowel cancer outcomes.   If we can find interventions that help to increase participation in screening programmes amongst lower income groups, we may be able to reduce the health inequalities that exist in bowel cancer outcomes.  

5 July 2022

• For Researchers

Government update on the Clinical Research Vision: More needed to go beyond recovery?

Is the Government's implementation plan for its 10-year clinical research vision any more than just rhetoric? Our policy team give us the low-down... Is the Government's implementation plan for its 10-year clinical research vision any more than just rhetoric? Our policy team give us the low-down...

30 June 2022

• Health & Medicine

New insights on self-sampling for cervical cancer screening

Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician. Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician.

27 April 2022

• Science & Technology

How we are working with industry to translate research into real benefits for patients 

You may not know that as well as funding cancer research, we also work with industry and academia to develop promising ideas and turn them into real benefit for patients. Find out about Cancer Research Horizons. You may not know that as well as funding cancer research, we also work with industry and academia to develop promising ideas and turn them into real benefit for patients. Find out about Cancer Research Horizons.

26 April 2022

• Science & Technology

A urine test for bladder cancer: What’s the latest?

Less than a year after The University of Birmingham had partnered with Nonacus to produce a urine test for bladder cancer, the first results are in. Less than a year after The University of Birmingham had partnered with Nonacus to produce a urine test for bladder cancer, the first results are in.

16 April 2022

• Science & Technology

Detecting multiple cancers with a ‘simple' blood test: Where are we?

A blood test capable of catching any cancer at an early stage before any symptoms may sound like science fiction but just how close are researchers to making it a reality? A blood test capable of catching any cancer at an early stage before any symptoms may sound like science fiction but just how close are researchers to making it a reality?

14 April 2022

• For Researchers

A new approach to cancer immunotherapy

Forty years ago, hints of a new component of the immune system caused a stir. Here, we chart the story of gamma delta T cells from discovery to clinical trials... Forty years ago, hints of a new component of the immune system caused a stir. Here, we chart the story of gamma delta T cells from discovery to clinical trials...

18 March 2022